EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Embolic Stroke of Undetermined Source · Atrial Fibrillation New Onset

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom
Contact: Study coordinator (Vassilios S. Vassiliou, PhD) · v.vassiliou@uea.ac.uk · 07443911905

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Echocardiographic Predictors of Atrial Fibrillation

Atrial Fibrillation · Stroke, Ischemic · Embolic Stroke of Undetermined Source

Abroad (travel likely)Recruiting

Tulln, Austria

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

Ischemic Stroke · Embolic Stroke of Undetermined Source · Patent Foramen Ovale (PFO)

Abroad (travel likely)Recruiting

Taichung, Taiwan · Taipei, Taiwan

High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)

Carotid Artery Disease · Symptomatic Carotid Artery Stenosis · Carotid Artery Stenting

Abroad (travel likely)Recruiting

Solingen, Germany

Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause

Embolic Stroke of Undetermined Source

Abroad (travel likely)Recruiting

Seoul, South Korea